Table:
begin	end	state
1	19	non-cytoplasmic
20	49	transmembrane
50	60	cytoplasmic
61	82	transmembrane
83	108	non-cytoplasmic
109	135	transmembrane
136	146	cytoplasmic
147	163	transmembrane
164	168	non-cytoplasmic
169	188	transmembrane
189	199	cytoplasmic
200	224	transmembrane
225	258	non-cytoplasmic
259	280	transmembrane
281	315	cytoplasmic
316	337	transmembrane
338	355	non-cytoplasmic
356	380	transmembrane
381	390	cytoplasmic
391	411	transmembrane
412	416	non-cytoplasmic
417	443	transmembrane
444	463	cytoplasmic
464	488	transmembrane
489	505	non-cytoplasmic

Input:
>SM_b20726
MGTFDFLLQGLLVAAQPMNLLYALIGVTLGTAVGVLPGIGPALTVALLLPVTYQLDPAGS
LIMFAGIYYGGMYGGSTTSILLNTPGESASIVTALEGNKMARAGRGGPALATAAIGSFVA
GLIATLGLAFIAPYIVKLALVFGPREYFALMVLAFVTVSSAFGDSTLRGLTSLFIGLTLA
CIGIDQLTGQARLSFGVPDLLDGIEVTTLAVAMFAIGETLFIAAQGDRGPDKVEAVRGSV
WMSATDWARSWKPWLRGTFIGFPIGAMPAGGAEIGTFLSYAAEKRLTKHPEEFGNGAIEG
VAGPEAANNASAAGTLVPLLTLGLPTTATAAIMLAGFQQYGLQPGPLLFATNPQLVWGLI
ASLLIANFMLLVLNLPLIGLWVKLLTIPKPWLYAGILLFATLGTIGANPSVFELGMLLAF
GLLGYVMRVFGYPIAPVVVGLILGPLAEQQLRRALSISQGDITVLFTSPIAAVLLVIAAL
ALVVPLILRARGRGEVLAQLAASED

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server